Paper · 14486

Ionizing radiation and the immune response.

Anderson RE and 1 other. Adv Immunol, 1976. Cited by 298 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Ionizing radiation and the immune response. Papers, record 14486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14486

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Ionizing radiation and the immune response.; PubMed
Journal: Adv Immunol; PubMed
Year: 1976; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S., Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/14486/; PubMed
DOI: https://doi.org/10.1016/s0065-2776(08)60331-4; PubMed
The journal: https://conductscience.org/library/journal-index/0370425; PubMed
Citations, by iCite: 298; iCite
Relative citation ratio, by iCite: 7.25; iCite
Revised in PubMed: 2019-10-27; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	Anderson RE	R E
2	Warner NL	N L

Source PubMed

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Immunity	Major topic
Immunity, Cellular	Major topic
Radiation, Ionizing	Major topic
Animals
Antibody Formation
B-Lymphocytes
Cell Movement
Dose-Response Relationship, Radiation
Ferrets
Graft Rejection
Guinea Pigs
Haplorhini
Humans
Immune Tolerance
Lymph Nodes
Lymphocytes
Macrophages
Mice
Neoplasms, Radiation-Induced
Neutrophils
Rabbits
Radiation Tolerance
Rats
Spleen
T-Lymphocytes
Thymus Gland

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by101

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 298 citations.

PMID	Title	Journal	Year	In Papers	Source
41,993,208	Rational modulation of immune mechanisms synergizes the anti-tumor effects of targeted radiation therapy in pre-clinical models.	Front Immunol	2026	https://conductscience.org/library/papers/41993208	PubMed
40,666,094	Advances in radiotherapy enhancing the efficacy of immune checkpoint inhibitors in malignant.	Front Oncol	2025	https://conductscience.org/library/papers/40666094	PubMed
40,309,477	Structural and temporal dynamics analysis on immune response in low-dose radiation: History, research hotspots and emerging trends.	World J Radiol	2025	https://conductscience.org/library/papers/40309477	PubMed
38,982,371	Host defense alteration in Caenorhabditis elegans after evolution under ionizing radiation.	BMC Ecol Evol	2024	https://conductscience.org/library/papers/38982371	PubMed
38,033,759	Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio.	Clin Transl Radiat Oncol	2024	https://conductscience.org/library/papers/38033759	PubMed
36,555,814	Gamma-Tocotrienol Modulates Total-Body Irradiation-Induced Hematopoietic Injury in a Nonhuman Primate Model.	Int J Mol Sci	2022	https://conductscience.org/library/papers/36555814	PubMed
36,341,366	Monocyte programming by cancer therapy.	Front Immunol	2022	https://conductscience.org/library/papers/36341366	PubMed
35,657,768	Lifelong cytomegalovirus and early-LIFE irradiation synergistically potentiate age-related defects in response to vaccination and infection.	Aging Cell	2022	https://conductscience.org/library/papers/35657768	PubMed
34,299,373	Microbeam Radiotherapy-A Novel Therapeutic Approach to Overcome Radioresistance and Enhance Anti-Tumour Response in Melanoma.	Int J Mol Sci	2021	https://conductscience.org/library/papers/34299373	PubMed
33,827,904	Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?	J Immunother Cancer	2021	https://conductscience.org/library/papers/33827904	PubMed

1 to 10 of 101

See all 101 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/14486

GET https://conductscience.org/api/papers/v1/14486/cited_by?page=2

API reference For AI assistants